Inhibin B
Ordering Recommendation

Use to differentiate ovarian tumor with normal CA 125 as stromal or mucinous epithelial tumor. May be used for monitoring recurrence of stromal ovarian tumors.

Quantitative Enzyme-Linked Immunosorbent Assay
Wed, Fri
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Serum separator tube or plain red. 
Specimen Preparation
Transport 0.5 mL serum. (Min: 0.2 mL) 
Storage/Transport Temperature
Unacceptable Conditions
Room temperature specimens. Hemolyzed or lipemic specimens. 
After separation from cells: Ambient: Unacceptable; Refrigerated: 48 hours; Frozen 1 month 
Reference Interval
0-6 yrs: 40-630 pg/mL
7-10 yrs :35-170 pg/mL
11-18 yrs: 50-475 pg/mL
19-45 yrs: 40-450 pg/mL
Greater than or equal to 46 years: less than 200 pg/mL
0-6 years: less than 73 pg/mL
7-10 years: less than 130 pg/mL
11-12 years: less than 186 pg/mL
13-18 years: less than 360 pg/mL
Pre-menopausal: less than 290 pg/mL
Follicular phase: 10-290 pg/mL
Post-menopausal: less than or equal to 16 pg/mL

Interpretive Data
This test is performed using the Beckman Coulter Inhibin B ELISA kit. Values obtained with different methodologies or kits cannot be used interchangeably.

Compliance Statement D: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Component Test Code*Component Chart NameLOINC
0070413Inhibin B34319-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.